Crimean-Congo hemorrhagic fever

Last reviewed March 21, 2026

🖨 Print for my doctor Advocacy Hub →

ORPHA:99827A98.0

Who is this for?

Show terms as

1Active trials 8Specialists 8Treatment centers

Where are you in your journey?

ℹ

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.

Report missing data

Overview

Also known as:

CCHF Congo fever Congo hemorrhagic fever Crimean hemorrhagic fever

Clinical phenotype terms— hover any for plain English:

Increased circulating IgM levelHP:0003496Capillary leakHP:0030005Increased circulating IgG concentrationHP:0003237ViremiaHP:0020071Stiff neckHP:0025258Decreased prothrombin timeHP:0032198

Orphanet ↗NORD ↗

FDA & Trial Timeline

4 events

Apr 2026Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-Care

Liverpool School of Tropical Medicine — NA

TrialNOT YET RECRUITING

Jul 2025Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever

HDT Bio — PHASE1

TrialRECRUITING

Jul 2025UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHF

Liverpool School of Tropical Medicine — PHASE2

TrialNOT YET RECRUITING

May 2025Development of a Rapid Diagnostic Test to Identify Crimean-Congo Hemorrhagic Fever - Research and Development Testing

Liverpool School of Tropical Medicine

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Crimean-Congo hemorrhagic fever.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →

Phase 11 trial

Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever

Phase 1

Actively Recruiting

PI: Malcolm Duthie, PhD (HDT Bio) · Sites: San Antonio, Texas · Age: 18–64 yrs

Specialists

8 foundView all specialists →

MP

Malcolm Duthie, PhD

Specialist

PI on 1 active trial

Active trials Directions Travel grants

AP

Aydın Erenmemisoglu, MD PhD

Specialist

PI on 1 active trial

Active trials Directions Travel grants

SP

Soo Aleman, MD, PhD

Specialist

PI on 1 active trial

Active trials Directions Travel grants

FP

Florian Marks, PhD

Specialist

Severe acute respiratory syndrome Typhoid

PI on 3 active trials

Active trials Directions Travel grants

EM

Emmanuel Bottieau, MD

Specialist

Central nervous system tuberculosis Cryptococcosis

PI on 2 active trials

Active trials Directions Travel grants

ER

Elizabeth Rini

LYNCHBURG, VA

Specialist

PI on 1 active trial

Active trials Directions Travel grants

LM

Luke C Mullany

Specialist

PI on 1 active trial

Active trials Directions Travel grants

LR

Lucy E Read

Specialist

PI on 1 active trial

Active trials Directions Travel grants

Treatment Centers

8 centers

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Crimean-Congo hemorrhagic fever.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Crimean-Congo hemorrhagic feverForum →

No community posts yet. Be the first to share your experience with Crimean-Congo hemorrhagic fever.

Start the conversation →

Latest news about Crimean-Congo hemorrhagic fever

Disease timeline:

New recruiting trial: Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever

A new clinical trial is recruiting patients for Crimean-Congo hemorrhagic fever

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Crimean-Congo hemorrhagic fever

Are there clinical trials for Crimean-Congo hemorrhagic fever?

Yes — 1 recruiting clinical trial is currently listed for Crimean-Congo hemorrhagic fever on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Crimean-Congo hemorrhagic fever?

8 specialists and care centers treating Crimean-Congo hemorrhagic fever are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.